Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Recruiting 5Active not recruiting 2Suspended 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Ovarian Neoplasms 1Osteosarcoma 1Neuroblastoma 1Neoplasm Metastasis 1Myelodysplastic Syndromes 1

Interventions

Specimen Handling 4Biopsy 4Magnetic Resonance Spectroscopy 3vactosertib 1trastuzumab deruxtecan 1trastuzumab biosimilar HLX02 1pegamotecan 1neratinib 1ipatasertib 1fludarabine phosphate 1binimetinib 1aldesleukin 1X-Rays 1Trastuzumab 1Taxes 1Surveys and Questionnaires 1Phantoms, Imaging 1Paclitaxel 1PF-05280014 1Ontruzant 1Ogivri 1Nivolumab 1NUC-1031 1N-acetylcochinol-O-phosphate 1Ipilimumab 1Interleukin-2 1IL32 protein, human 1Gemcitabine 1Cyclophosphamide 1CTLA-4 Antigen 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Suspended × Neoplasm Metastasis × X-Rays × Clear all
NCT04840589 2026-05-13

Testing the Combination of ZEN003694 and Nivolumab With or Without Ipilimumab in Solid Tumors

National Cancer Institute (NCI)

Phase 1 Suspended
66 enrolled
Gynecologic

Neoplasm Metastasis, Ovarian Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡